Abstract. ln highly endemic settings for hepatitis B virus (HBV) infection such as Senegal, access to HBV prevention and care is rapidly evolving. ln this context, all medical practitioners should have baseline knowledge on HBV infection and promote access to vaccination, screening, and care. A knowledge and attitudes survey on HBV infection was conducted among a randomly selected sample of medical practitioners in Senegal. Participants were asked to fill-out a questionnaire on the HBV epidemiology, prevention, and treatment, A 60-item knowledge score was computed; the lower quartile of the observed score was used to define poor knowledge. Factors associated with poor knowledge were assessed using a logistic regression model. A tolal of 127 medlcal practltioners completed the questionnaire. Only 14 (11,0%) participañts knewthat HBVvaccine could besafely administered to pregnantwomen and 65 (51 .2%)to newborns. Olderpractitioners þ 40 ygqrs) as well as general practitioners (compared with specialists) were more likely to have a poor knowledge score with odds ratios (ORs) of 3.1 (95% confidence interval [Cl] 1.0-9.2) and 2.6 (95% C|1.0-7.3), respectivety. Practitioners who declared not to recommend HBV screening frequently during their consultation were more likely to present a poor knowledge score [OR: 3.0; (95% Cl 1.1-8.2I. As universal HBV screening is being promoted in countries with endemic HBV infection, our finding that poor screening attitudes were associated with a poor knowledge is of concern. There is a need to raise awareness of medical practitioners in Senegal toward universal HBV screening and early vaccination of newborns.
observed score was used to define poor knowledge. Factors associated with poor knowledge were assessed using a logistic regression model. A tolal of 127 medlcal practltioners completed the questionnaire. Only 14 (11,0%) participañts knewthat HBVvaccine could besafely administered to pregnantwomen and 65 (51 .2%)to newborns. Olderpractitioners þ 40 ygqrs) as well as general practitioners (compared with specialists) were more likely to have a poor knowledge score with odds ratios (ORs) of 3.1 (95% confidence interval [Cl] 1.0-9.2) and 2.6 (95% C|1.0-7.3), respectivety. Practitioners who declared not to recommend HBV screening frequently during their consultation were more likely to present a poor knowledge score [OR: 3.0; (95% Cl 1.1-8.2I. As universal HBV screening is being promoted in countries with endemic HBV infection, our finding that poor screening attitudes were associated with a poor knowledge is of concern. There is a need to raise awareness of medical practitioners in Senegal toward universal HBV screening and early vaccination of newborns. (HBV) is highly endemic in sub-Saharan Africa. ln Senegal, the prevalence of chronic HBV infection ranges from 11 to 15% in adults.l-3 HBV infection is a leading cause of liver disease and the most important risk factor for liver cancer in sub-saharan Africa.a '5 Although an effective vaccine against HBV infection is available since the early 80s, HBV vaccination as part of the expanded program on immunization has only been introduced since 2005 with several challenges. First, the vaccination coverage remains low with only 46% of children presenting serological protection against HBV (anti-HBs antibody titer > 10 lU/mL) among 486 Senegalese hospitalized children.6,7 Second, the timing of administration is suboptimal: HBV vaccination was first introduced as a combined vaccine (DTP- HepB-Hib) with a first dose at 6 months limiting its efficacy against mother-to-chiid transmission of HBV. Aside these challenges, it takes decades for a preventive strategy based on universal vaccination to reach its full effectiveness. ln the meantime, thousands of chronically infected adults are in need for screening and care. Although universal use of effective anti-HBVtherapy is still challenging, there are elements supporting a future expanded access to these treatments. ln Senegal, tenofovir is part of the recommended first-line antiretroviral therapy regimen for HIV-infected patients and could become available for H|V-uninfected 
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